Logo for Poseida Therapeutics Inc

Poseida Therapeutics Investor Relations Material

Latest events

Logo for Poseida Therapeutics Inc

Study Result

Poseida Therapeutics
Logo for Poseida Therapeutics

Study Result

28 Sep, 2024
Logo for Poseida Therapeutics

Q2 2024

5 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Poseida Therapeutics Inc

Access all reports
Poseida Therapeutics, Inc. (PSTX) is a clinical-stage biopharmaceutical company that specializes in developing innovative cell and gene therapies. These therapies aim to provide cures for cancers and genetic diseases by leveraging non-viral gene engineering technologies. Poseida's product pipeline includes both autologous and allogeneic chimeric antigen receptor T cell (CAR-T) therapies, which are at the forefront of treating hematological malignancies and solid tumors. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.